| Liu, Jing |
NCT04624854: Dual Anti-Platelet Therapy in Patients With Coronary Multi-Vessel Disease (DAPT-MVD) |
|
|
| Active, not recruiting | 4 | 8250 | RoW | Clopidogrel and Aspirin dual-antiplatelet therapy, Aspirin monotherapy | Harbin Medical University, Chinese Society of Cardiology, Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Artery Disease, Myocardial Ischemia, Acute Coronary Syndrome, Heart Diseases, Syndrome Heart Disease, Cardiovascular Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Coronary Disease, Vascular Diseases | 04/25 | 04/25 | | |
ECLIPSE, NCT05416840: Effects and Safety of Clonidine Patch on Young and Middle-aged Smokers With Mild Hypertension |
|
|
| Not yet recruiting | 4 | 92 | RoW | Clonidine controlled-release patch, Amlodipine | Jing Liu | Hypertension | 11/26 | 12/26 | | |
NCT05745259: Thrombolysis Treated With TNK-tPA in Acute Ischemic Stroke Patients （3T Stroke-Ⅲ） |
|
|
| Recruiting | 3 | 1630 | RoW | Alteplase, rt-PA, Tenecteplase, TNK-tPA | Beijing Tiantan Hospital, Jiangsu FENG HUA Biotech Pharmaceutical Co., Ltd, The Place Pharmaceutical(Jiangsu) Co., Ltd | Acute Ischemic Stroke | 11/23 | 03/24 | | |
BENCH, NCT04939142: A Study of Evaluating the Safety and Efficacy of ATG-010, Bortezomib, and Dexamethasone (SVd) Versus Bortezomib and Dexamethasone (Vd) in Patients With Relapsed or Refractory Multiple Myeloma (RRMM) |
|
|
| Active, not recruiting | 3 | 150 | RoW | SVd (Selinexor+Bortezomib+dexamethasone), Vd (Bortezomib+dexamethasone) | Antengene Corporation | Relapsed or Refractory Multiple Myeloma | 07/24 | 10/24 | | |
| Completed | 3 | 806 | Europe, Canada, US, RoW | Placebo, Mepolizumab | GlaxoSmithKline, PPD DEVELOPMENT, LP | Pulmonary Disease, Chronic Obstructive | 08/24 | 08/24 | | |
|
|
|
|
|
NCT04578613: ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL |
|
|
| Recruiting | 3 | 218 | RoW | ICP-022, Chlorambucil, Rituximab | Beijing InnoCare Pharma Tech Co., Ltd. | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | 12/24 | 06/25 | | |
NCT06532539: Cadonilimab With Chemoradiation for Recurrent and Oligometastatic Endometrial Carcinoma |
|
|
| Recruiting | 2 | 30 | RoW | Paclitaxel and Cisplatin, TP, Cadonilimab, AK104, Radiotherapy | Shandong Cancer Hospital and Institute | Endometrial Neoplasms, Neoplasm Recurrence, Local, Neoplasm Metastasis | 05/25 | 05/26 | | |
NCT04970121: Efficacy and Safety of Duloxetine in Chinese Solid Tumor Patients with Taxanes-induced Painful Peripheral Neuropathy |
|
|
| Recruiting | 2 | 100 | RoW | Duloxetine, Chemotherapy containing taxanes | Yan Yang, MD, Ph.D | Chemotherapy-induced Peripheral Neuropathy, Pain, Solid Tumor | 07/25 | 12/25 | | |
NCT06757504: Evaluate the Efficacy and Safety of TTYP01 Tablets in Adolescents and Children With ASD |
|
|
| Recruiting | 2 | 150 | RoW | TTYP01 Tablets (12mg or 18mg), Placebo (Simulant TTYP01 Tablets) | Shanghai Auzone Biological Technology Co., Ltd. | Autism Spectrum Disorder (ASD) | 02/26 | 05/26 | | |
FUMANBA-1, NCT05066646: A Phase 1/2 Study of a Fully Human BCMA-targeting CAR (CT103A) in Patients With Relapsed/Refractory Multiple Myeloma |
|
|
| Recruiting | 1/2 | 132 | RoW | CT103A | Nanjing IASO Biotherapeutics Co.,Ltd | Multiple Myeloma | 10/22 | 06/24 | | |
| Active, not recruiting | 1/2 | 121 | RoW | CAR-BCMA T Cells | CARsgen Therapeutics Co., Ltd., Beijing Chao Yang Hospital, The First Affiliated Hospital of Soochow University, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Tianjin Medical University General Hospital, First Affiliated Hospital of Zhejiang University, Beijing Hospital, Shanghai Tongji Hospital, Tongji University School of Medicine, First Affiliated Hospital of Wenzhou Medical University, Xiangya Hospital of Central South University, Peking University People's Hospital, Qilu Hospital of Shandong University, Sun Yat-sen University, First Affiliated Hospital, Sun Yat-Sen University | Multiple Myeloma | 12/24 | 12/25 | | |
NCT04711980: Post-marketing Evaluation of Mudan Granule Intervention on Type 2 Diabetic Peripheral Neuropathy |
|
|
| Not yet recruiting | 1 | 402 | RoW | Mudan granule, Mudan particle, Placebo, Placebos | Fengmei Lian, Peking Union Medical College Hospital, Beijing Hospital, Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Affiliated Hospital of Qingdao University, Chengdu University of Traditional Chinese Medicine, The Fourth People's Hospital of Chongqing, Zhengzhou Yihe Hospital Affiliated to Henan University, Zhu Xianyi Memorial Hospital of Tianjin Medical University, The Third Hospital of Xi'an, Huashan Hospital, Gansu Provincial People's Hospital, Shenzhen Hospital of Guangzhou University of Traditional Chinese Medicine, Affiliated Hospital of Changchun University of Chinese Medicine | Diabetic Peripheral Neuropathy Type 2 | 02/22 | 09/22 | | |
NCT05627063: A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK121-NX in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 169 | US, RoW | ABSK121-NX | Abbisko Therapeutics Co, Ltd | Solid Tumor | 03/25 | 06/25 | | |
| Enrolling by invitation | N/A | 3000 | RoW | Cardiovascular risk factors, Aging related health problems | Beijing Institute of Heart, Lung and Blood Vessel Diseases | Cardiovascular Diseases, Cardiovascular Risk Factor, Aging Problems, Smell Disorder, Sleep | 03/21 | 03/21 | | |
NCT04658992: The Registration on the Use of Feilike Heji in Minors |
|
|
| Recruiting | N/A | 3000 | RoW | | China Academy of Chinese Medical Sciences | Bronchial Asthma | 12/21 | 03/22 | | |
| Recruiting | N/A | 10254 | RoW | | Limeng Chen | Chronic Kidney Diseases, Chronic Kidney Disease-Mineral and Bone Disorder | 12/24 | 12/24 | | |
NCT06211166: Assessment of Measurable Residual Disease in Allo-HSCT Using Digital Polymerase Chain Reaction |
|
|
| Recruiting | N/A | 300 | RoW | Digital PCR, Quantitative PCR, MFC | Peking University People's Hospital | Acute Leukemia, MDS, MDS/MPN, CML | 12/25 | 12/27 | | |
NCT05774288: Safety and Efficacy of Cera™ Patent Foramen Ovale Occluders. |
|
|
| Recruiting | N/A | 244 | RoW | Cera™ patent foramen ovale occluders, Another patent foramen ovale occluders | Lifetech Scientific (Shenzhen) Co., Ltd. | Patent Foramen Ovale, Cryptogenic Stroke | 04/25 | 06/29 | | |
NCT05423275: Light and Ion Maintenance In Treatment for Depression (LIMIT-D): Feasibility Study |
|
|
| Recruiting | N/A | 100 | Canada | Negative ion therapy, Light therapy | University of British Columbia, University of Toronto, Université de Montréal, Canadian Institutes of Health Research (CIHR), McMaster University, Ontario Brain Institute, Centre for Addiction and Mental Health | Major Depressive Disorder, Recurrent, in Remission | 12/26 | 06/27 | | |
| Not yet recruiting | N/A | 200 | RoW | smart wearable device | Jing Liu, HUAWEI | Masked Hypertension | 06/24 | 07/24 | | |
NCT05498974: China Diabetes Type 1 Study (CD1S) by China Alliance for Type 1 Diabetes |
|
|
| Recruiting | N/A | 20000 | RoW | Standard type 1 diabetes management model constructed by China Alliance for Type 1 Diabetes in each center | Second Xiangya Hospital of Central South University | Type1diabetes, Diabetes | 12/35 | 12/35 | | |
